1,3-diethyl-8-phenylxanthine and n(6)-cyclopentyladenosine

1,3-diethyl-8-phenylxanthine has been researched along with n(6)-cyclopentyladenosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Craig, RH; Daluge, SM; Earl, CQ; Linden, J; Patel, A1
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1

Other Studies

3 other study(ies) available for 1,3-diethyl-8-phenylxanthine and n(6)-cyclopentyladenosine

ArticleYear
125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:4

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Affinity Labels; Algorithms; Animals; Binding, Competitive; Brain; Cattle; Humans; Iodine Radioisotopes; Iodobenzenes; Isotope Labeling; Kinetics; Ligands; Membranes; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sodium Chloride; Structure-Activity Relationship; Theophylline; Xanthines

1988
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Molecular pharmacology, 1999, Volume: 56, Issue:4

    Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines

1999
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007